Interactions between riluzole and ABCG2/BCRP transporter
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative fatal disease. Drugs used in this disease need to cross the blood–brain barrier (BBB). Only riluzole is approved for ALS treatment. We have investigated riluzole as a breast cancer resistance protein (BCRP) substrate by studying its brain tr...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , , , |
| Format: | article |
| Published: |
2009
|
| Online Access: | http://hdl.handle.net/10725/4498 http://dx.doi.org/10.1016/j.neulet.2008.12.061 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php http://www.sciencedirect.com/science/article/pii/S0304394009000020 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|